PROVIDER PROFILE · NPI 1871639021

Loretta BergesenF.N.P.,RNCS

Nurse PractitionerDanvers, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

470

Unique beneficiaries

—

Total services

849

Distinct HCPCS

Medicare payment

$47K

Peer benchmark

Total Medicare services vs. 5,906 Nurse Practitioner providers in MA — top quintile (cohort median 289).

PRESCRIBING · PART D · 2024

Total Rx claims

2,148

Beneficiaries

—

Total drug cost

$138K

Distinct drugs

Brand share

10.8%

Top prescribed drugs

Atorvastatin Calcium164 claims

Amlodipine Besylate161 claims

Omeprazole155 claims

Lisinopril123 claims

Levothyroxine Sodium95 claims

QUALITY · MIPS · 2024

Final MIPS score

92.0

Quality

76.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.71%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Loretta Bergesen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NORTHEAST HOSPITAL CORPORATION	148	1,272
Mauri Cohen Internal Medicine · Danvers, MA	63	295
Lindsay Pearce Diagnostic Radiology · Beverly, MA	19	44
CHAFEY, JAMES	16	33
Zhao Liu Endocrinology · Danvers, MA	15	51
Kathleen Walsh Diagnostic Radiology · Beverly, MA	12	30
Timothy Frey Diagnostic Radiology · Boston, MA	11	49

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history